PDCD1 and cancer: This potential as a therapy was first observed in mice with cancer but no microbiome, as these animals demonstrated a different response when treated with anticancer drugs, including cisplatin, cyclophosphamide, and anti-programmed cell death 1 protein (PD-1) immunotherapy [159,160].